After years of laying the foundations, China Biotech Inc. is being pursued by multinationals looking for innovative candidates to commercialize in both China and globally, executives and deals from the just concluded J.P Morgan Global Healthcare Conference show.
MNCs in hot pursuit of China biotech, JPM Deals show • Source: Shutterstock
Founded only one year ago with a leading asset licensed from Jiangsu Hengrui Medicine Co., Ltd., Chinese bioventure Aiolos Bio is now being acquired by GSK plc in a major deal.
Set up two years ago and dedicated to kidney conditions, another new Chinese company, SanReno Therapeutics, is being
